Open AccessManaging the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
Author(s) -
Maria E. Cabanillas,
Shunji Takahashi
Publication year - 2020
Publication title -
opuholi golovy i šei
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 1
eISSN - 2411-4634
pISSN - 2222-1468
DOI - 10.17650/2222-1468-2019-9-4-49-61
Subject(s) - lenvatinib , thyroid cancer , medicine , adverse effect , refractory (planetary science) , oncology , radioiodine therapy , cancer , biology , astrobiology
.